Navigation Links
Making Change: The Cost of Being Transgender

on the Internet, with a family physician, or through a community organization. But many low-income parents can't afford access to those resources.

Children from poorer families are more likely to be thrown out of their homes and end up on the streets.

Though the transgender community in the United States is small, roughly estimated at between 1 and 3 million people, it represents a broad diversity of people.

"Transgender can be anything from feeling internal body dysmorphia [an altered body image] to acting on it, as with cross-dressing, to actually changing your body through hormones, silicone injections and surgery," said Cris Beam, a journalist who spent seven years following a group of transgender youths on the streets of Los Angeles for her book "Transparent."

Those who want surgery and can afford it can spend $10,000 to $20,000 for a sex-change operation.

But for most transgender people, surgery is not an option. Their primary concern is simply making ends meet.

"The vast majority of [transgender] people are poor," said Chris Daley, director of the Transgender Law Center. "Being trans affects their economic health and means unemployment and underemployment. There is a real material cost in transitioning."

In San Francisco -- arguably the most transgender friendly city in the country and home to the minority's largest population -- 60 percent of transgender people make less than $15,300.

Experts and advocates say that people obviously in the middle of transition are often discriminated against when looking for work. Those with jobs often cannot get their health insurance to cover the cost of hormone therapy.

"They're often turned away from places like McDonald's if they're visibly trans -- the most basic workplaces and most basic jobs," said Ray Carannante, associate director of the Gender Identity Project at the Lesbian, Gay, Bisexual and Transgender Community Ce
'"/>




Page: 1 2 3 4 5

Related medicine news :

1. Hyderabad To Have Asia’s First Catheter Making Uni
2. Making Fortification Mandatory In Order To Reduce Birth Defects
3. Making operation and recovery time shorter
4. Making MRIs Safe for Patients With Implantable Heart Devices
5. Novel Study Unravels a New Dimension to Decision Making
6. Distinct Brain Sections Are Activated While Making Risky Decisions
7. Sexy Images and Lingerie Challenge A Man’s Decision Making Skill
8. Decision-Making Enabled By Neurons: Value Assigned To Available Choices.
9. Making Budhia run 65 km absolutely cruel,says Infosys chief
10. Making a mocktail of chemical cocktail in children’s blood
11. Antihistamine Proved Ineffective in Making Kids to Sleep
Post Your Comments:
(Date:10/8/2008)... , Dr. Robert Bernstein, ...rocedure for hair restoration is featured on the O...atment. , New York, NY (P...atures Dr. Bernstein discussing his pioneering fol...n the newest diagnostic and treatment techniques f...
(Date:10/7/2008)... U.S. recommendations reflect previously publ...LAS, Oct. 7 /PRNewswire-USNewswire/ -- Guidelines,...epartment of Health and,Human Services (HHS) were ...ts Medicine (ACSM) and the American Heart Associat...hed physical activity recommendations,last year, a...
(Date:10/7/2008)ANAHEIM, Calif., Oct. 7 /PRNewswire-USNewswire/ -- CHADD, the nation,s,largest organization serving people affected by AD/HD, will hold its Annual,International Conference on AD/HD November 12-1
(Date:10/7/2008)... Compression ultrasound similar to more expensive... , TUESDAY, Oct. 7 (HealthDay News) -- An o...leg -- called deep vein thrombosis, or DVT -- is a...esearch says. , European researchers found that...alled compression or duplex ultrasound -- was as g...
Breaking Medicine News(10 mins):Health News:Pioneering Hair Transplant Doctor Explains Procedure on Oprah Winfrey Show 2Health News:ACSM, AHA Support Federal Physical Activity Guidelines 2Health News:ACSM, AHA Support Federal Physical Activity Guidelines 3Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...are commonly used for a number of painful complai... attack and stroke//. This has lead to an order by...rugs will have to carry a warning along with the i...turers. Doctors are being informed of the small ...
...nt study, women with a twin are at upto 5 times hi...an those without one//. The study was conducted o... The risk of premature ovarian failure (POF) at th...s than women from the general population. POF caus...
...lie Minogue with breast cancer has led to confusio...o get breast cancer//. Cancer Research UK said t...re likely to strike the under-70s than women over ...en revealed that 77 per cent of them thought that ...
...safe for administration in babies and toddlers, re...of flu shots//. Two flu seasons back, the federal...the age 6 months to 2 years and their family membe...ise in the number of children getting vaccinated. ...
Other Medicine News:
(Date:10/7/2008)... VIENNA, Va., Oct. 7 /...y that it has entered into a Material Transfer,Agr...h Clinical Center,(NIHCC) and the laboratory of Dr... molecular basis of changes to the tumor microenvi... Dr. Marincola is the Chief of,the Infectious Dise...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Sc...wire-FirstCall/ -- Ironwood,Pharmaceuticals, Inc. ...,Inc. (NYSE: FRX ) today announced the presentati...clotide,s safety and efficacy in 420 patients with...). Analysis of the data,indicates that once- daily...
(Date:10/7/2008)... Several abstracts highlighting CIMZIA,s long...hn,s disease patients presented at American Colleg... /- Data from two studies,p...of Gastroenterology,(ACG) Annual Meeting demonstra...PEGylated anti-TNF alpha (Tumor Necrosis Factor al...
(Date:10/7/2008)... - Planned 15 Patient Cohort Enrolled in Stage A...ombination With Carboplatin and Paclitaxel -, TUS...grine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a cl...monoclonal antibodies for the treatment of cancer ...nced that it has completed,enrollment in the first...
Breaking Medicine Technology:CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Doctors See How Cancer Drug Can Damage Kidneys 14210 1Doctors See How Cancer Drug Can Damage Kidneys 14210 2Doctors See How Cancer Drug Can Damage Kidneys 14210 3New Tools Boost Alzheimers Awareness 14206 1New Tools Boost Alzheimers Awareness 14206 2New Tools Boost Alzheimers Awareness 14206 3WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 1WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 2WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 3WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 4WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 5WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 6WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 7WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 8WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 9WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 10WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 11WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 12The Makers of Conquer HA 28TM 29 Launch All Natural Double Strength Anti Inflammatory Formula 14200 1The Makers of Conquer HA 28TM 29 Launch All Natural Double Strength Anti Inflammatory Formula 14200 2
The 6303 is an affordable path to Sonesta flexibility. Three motors provide full height, seat, and back adjustments. Packaged with basic accessories, the 6303 accepts the full line of Sonesta add-ons
For complete unobstructed imaging coverage for a wide range of urological procedures, HealthTronics urodynamics Chair/Table is the answer.
The Advanced Model BR2 Bilirubin STAT-Analyzer® provides a rapid, accurate determination of total and direct bilirubin in neonates. And because it's so compact and easy to use, it is appropriate
...e utilises a generic PCR amplification with biotin...on of an HLA locus. This is followed by hybridisat...nce Specific Oligonucleotide probes immobilised on...bes is referred to as a Reverse Line blot and thus...
Medicine Products: